Literature DB >> 2149916

The transverse rectus abdominis musculocutaneous free flap: a reliable alternative for delayed autologous tissue breast reconstruction.

A M Feller1, H W Hörl, E Biemer.   

Abstract

The use of the pedicled transverse rectus abdominis musculocutaneous (TRAM) flap has been established world-wide for breast reconstruction. Until now, application of a TRAM free flap, however, has only taken place in special circumstances. The advantages of a TRAM free flap (such as better and more vigorous perfusion than with a pedicled TRAM flap and greater freedom in reconstruction, as well as a lower incidence of weakening within the abdominal wall) are so conclusive that it has become our preferred procedure for breast reconstruction. Twenty-five patients have successfully undergone this procedure at our division. In 6 patients, the arterial or venous microanastomosis, or both, required revision without experiencing, however, total flap loss. Partial flap loss occurred in only 1 patient. All patients (including those having undergone revision) were satisfied with their reconstructed breast form. This satisfaction can be directly attributed to the fact that with this procedure, a desired breast form and volume can almost always be achieved.

Entities:  

Mesh:

Year:  1990        PMID: 2149916     DOI: 10.1097/00000637-199012000-00001

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  3 in total

1.  [Quality of life and patient satisfaction after breast reconstruction].

Authors:  N A Papadopulos; L Kovacs; A Baumann; S Ali; P Herschbach; G Henrich; E Biemer
Journal:  Chirurg       Date:  2006-07       Impact factor: 0.955

Review 2.  Immediate nipple-areola-sparing mastectomy reconstruction: An update on oncological and reconstruction techniques.

Authors:  Alexandre Mendonça Munhoz; Eduardo Montag; José Roberto Filassi; Rolf Gemperli
Journal:  World J Clin Oncol       Date:  2014-08-10

3.  Breast reconstruction with autologous tissue following mastectomy.

Authors:  Hr Teymouri; S Stergioula; M Eder; L Kovacs; E Biemer; Na Papadopulos
Journal:  Hippokratia       Date:  2006-10       Impact factor: 0.471

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.